Porphyria Cutanea Tarda: Clinical Trials

1 trial for Porphyria Cutanea Tarda, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Completed 1

Follow Porphyria Cutanea Tarda: new trials by email Literature Review of Porphyria Cutanea Tarda trials Research Report on Porphyria Cutanea Tarda

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pilot Trial of Deferasirox in the Treatment of Porphyria Cutanea Tarda
Deferasirox - Porphyria Cutanea Tarda
Phase 3CompletedUniversity of Texas Southwestern Medical Center102008-01-012014-02-10

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Digestive System Diseases (1)  ·  Genetic Diseases, Inborn (1)  ·  Liver Diseases (1)  ·  Metabolic Diseases (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Porphyrias (1)  ·  Porphyrias, Hepatic (1)  ·  Skin Diseases (1)  ·  Skin Diseases, Genetic (1)  ·  Skin and Connective Tissue Diseases (1)

Interventions

Deferasirox (1)

Sponsors

University of Texas Southwestern Medical Center (1)

Countries

United States (1)

Top investigators

Amit Pandya, M.D. (1)

Results publications

PMID 22911183